Moderna Stock - UBS analyst Eliana Merle upgraded Moderna stock to Buy from Neutral, but trimmed the price target. The Covid and RSV businesses alone are worth $123 a share, she says. https://t.co/PeyfmwdbuN

7:41am PDT - June 26th, 2023

UBS analyst Eliana Merle upgraded Moderna stock to Buy from Neutral, but trimmed the price target. The Covid and RSV businesses alone are worth $123 a share, she says. https://t.co/PeyfmwdbuN

3 retweets 0 likes -